These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 18061071

  • 1. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, Muller JE, Mittleman MA, TOVA Investigators.
    J Am Coll Cardiol; 2007 Dec 04; 50(23):2233-40. PubMed ID: 18061071
    [Abstract] [Full Text] [Related]

  • 2. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM, TOVA Investigators.
    Circulation; 2004 Mar 23; 109(11):1386-91. PubMed ID: 14993132
    [Abstract] [Full Text] [Related]

  • 3. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
    Whang W, Albert CM, Sears SF, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA, TOVA Study Investigators.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1090-5. PubMed ID: 15808769
    [Abstract] [Full Text] [Related]

  • 4. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 5. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG, Dougherty CM, MacMurdy KS, Raitt MH.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):739-47. PubMed ID: 22773022
    [Abstract] [Full Text] [Related]

  • 6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 7. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A, Trinquart L, Marijon E, Lavergne T, Waintraub X, Lepillier A, Chatellier G, Le Heuzey JY, EVADEF investigators.
    Am Heart J; 2009 Aug 08; 158(2):230-237.e1. PubMed ID: 19619699
    [Abstract] [Full Text] [Related]

  • 8. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators.
    J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874
    [Abstract] [Full Text] [Related]

  • 10. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug 01; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
    Stuber T, Eigenmann C, Delacrétaz E.
    Pacing Clin Electrophysiol; 2005 Jul 03; 28(7):702-7. PubMed ID: 16008807
    [Abstract] [Full Text] [Related]

  • 13. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP, Winters SL, Subacius H, Berger RD, Ellenbogen KA, Taylor SG, Schaechter A, Howard A, Kadish A, Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Pacing Clin Electrophysiol; 2009 Jun 03; 32(6):755-61. PubMed ID: 19545338
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA.
    J Cardiovasc Electrophysiol; 2012 Jul 03; 23(7):750-6. PubMed ID: 22353378
    [Abstract] [Full Text] [Related]

  • 15. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
    Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, EMPIRIC Trial Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):330-9. PubMed ID: 16843184
    [Abstract] [Full Text] [Related]

  • 16. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
    Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F.
    J Heart Lung Transplant; 2009 Jul 18; 28(7):733-5. PubMed ID: 19560703
    [Abstract] [Full Text] [Related]

  • 17. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2258-63. PubMed ID: 16360055
    [Abstract] [Full Text] [Related]

  • 18. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.
    Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B.
    J Cardiovasc Electrophysiol; 2005 May 20; 16(5):478-82. PubMed ID: 15877617
    [Abstract] [Full Text] [Related]

  • 19. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.
    Streitner F, Kuschyk J, Veltmann C, Brueckmann M, Streitner I, Brade J, Neumaier M, Bertsch T, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2007 Oct 20; 40(1):30-4. PubMed ID: 17851087
    [Abstract] [Full Text] [Related]

  • 20. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator.
    Arya A, Haghjoo M, Nikoo MH, Dehghani MR, Fazelifar AF, Sadr-Ameli MA.
    J Electrocardiol; 2006 Oct 20; 39(4):404-8. PubMed ID: 16895771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.